Skip to main content

Table 3 Moderating effects of key baseline characteristics on weight loss (primary outcome) at 6 months (n = 285)a

From: The community-based prevention of diabetes (ComPoD) study: a randomised, waiting list controlled trial of a voluntary sector-led diabetes prevention programme

 

Between group differenceb

Mean (95% CI)

Interaction term

p value

Site

0.829

 Exeter (n = 151)

−1.77 (−3.07 to − 0.46)

 Birmingham (n = 134)

−1.59 (−2.71 to − 0.48)

Gender

0.508

 Male (n = 124)

−1.87 (−3.43 to −0.31)

 Female (n = 161)

−1.43 (−2.40 to −0.45)

Age (yrs)

0.501

 <55 (n = 66)

−0.75 (−2.92 to 1.42)

 55–65 (n = 83)

−1.87 (−3.39 to − 0.36)

 65–75 (n = 136)

−2.16 (− 3.30 to − 1.02)

Baseline BMI (kg/m2)

0.101

 23.0–29.9 (n = 118)

−0.79 (− 1.91 to 0.34)

 30.0–36.9 (n = 130)

−1.99 (−3.36 to − 0.63)

 37.0–45.0 (n = 37)

−2.67 (−6.07 to 0.72)

Ethnicity

0.562

 White British (n = 211)

−2.03 (−3.09 to −0.96)

 Other (n = 74)

−1.10 (−2.65 to 0.45)

Deprivation

0.643

 Low (≤ England median IMD score) (n = 116)

−1.97 (−3.29 to −0.65)

 High (> England median IMD score) (n = 169)

−1.52 (−2.71 to −0.33)

  1. abased on intention-to-treat completers
  2. bAdjusted for baseline outcome value, site, age, gender and baseline BMI